Cambridge, MA – The Workers Compensation Research Institute (WCRI) recently released a new report that gathers in one place the numerous state regulations affecting prescription drugs in all 50 states, including those for injured workers.
“Across the country, states are grappling with an array of different regulatory strategies, overseen by different agencies, to address prescribing of medicine,” said Ramona Tanabe, WCRI’s executive vice president and counsel. “This report provides policymakers and system stakeholders with a basic understanding of the different strategies adopted by all states, and points to the regulations for those seeking more detail.”
The report, Workers’ Compensation Prescription Drug Regulations: A National Inventory, 2018, also provides information on some of the most prominent prescription drug issues stakeholders are concerned about in 2018, such as the following:
- Rules for Limiting and Monitoring Opioid Prescriptions
- Medical Marijuana Regulations
- Workers’ Compensation Drug Formularies
- Prescription Drug Monitoring Programs
- Price Regulations for Pharmacy- and Physician-Dispensed Drugs
- Drug Testing Regulations
The tables in this report were compiled from completed surveys of two agencies for each of the 50 states and the District of Columbia. Since prescription drug regulations are changing rapidly in the United States, the author points out that the information in this report is a snapshot in time, as of January 1, 2018.
The report was authored by Karen Rothkin.
For more information or to purchase a copy, click here: WCRI: Workers’ Compensation Prescription Drug Regulations: A National Inventory, 2018.